Leonardo Mirandola - 03 May 2024 Form 3 Insider Report for Kiromic Biopharma, Inc. (KRBPQ)

Role: CSO
Signature: /s/ Leonardo Mirandola
Issuer symbol: KRBPQ
Transactions as of: 03 May 2024
Net transactions value: $0
Form type: 3
Filing time: 09 May 2024, 17:29:00 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	KRBP	Restricted Stock Award						56,911	03 May 2024	Direct	F1
holding	KRBP	Restricted Stock Award						15	03 May 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	KRBP	Stock Options							03 May 2024	Common Stock	115	$199.20	Direct	F2
holding	KRBP	Restricted Stock Units							03 May 2024	Common Stock	28	$0.000000	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Stock Award vests on April 1, 2025.
F2	Immediately
F3	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of common stock for each RSU. 19 RSUs have vested and the remainder vest equally on a monthly basis until February 2025.